PMID- 20128048 OWN - NLM STAT- MEDLINE DCOM- 20100422 LR - 20201209 IS - 1793-6853 (Electronic) IS - 0192-415X (Linking) VI - 38 IP - 1 DP - 2010 TI - Curcumin and saikosaponin a inhibit chemical-induced liver inflammation and fibrosis in rats. PG - 99-111 AB - Curcumin and saikosaponin A as antioxidants improve antioxidant status. This study investigated the anti-inflammatory and antifibrotic actions of curcumin and saikosaponin A on CCl(4)-induced liver damage. Sprague-Dawley rats were randomly divided into control, CCl(4), CCl(4)+ curcumin (0.005%; CU), CCl(4) + saikosaponin A (0.004%; SS), and CCl(4) + curcumin + saikosaponin A (0.005% + 0.004%; CU + SS) groups. Carbon tetrachloride (40% in olive oil) at a dose of 0.75 ml/kg was injected intraperitoneally once a week. Curcumin and saikosaponin A were supplemented alone or in combination with diet 1 week before CCl(4) injection for 8 weeks. After 8-week supplementation, histopathological results showed hepatic collagen deposition was significantly reduced in the CU and SS groups, and activated nuclear factor-kappa B expression induced by CCl(4) in the liver was significantly inhibited by curcumin and/or saikosaponin A. Hepatic proinflammatory cytokines tumor necrosis factor-alpha, interleukin-1beta, and interleukin-6 were significantly inhibited, and anti-inflammatory cytokine interleukin-10 was significantly increased by supplementation with curcumin and/or saikosaponin A. Additionally, curcumin and/or saikosaponin A significantly reduced the increased levels of hepatic transforming growth factor-beta1 and hydroxyproline after CCl(4) treatment. Therefore, supplementation with curcumin and/or saikosaponin A suppress inflammation and fibrogenesis in rats with CCl(4)-induced liver injury. However, the combination has no additive effects on anti-inflammation and antifibrosis. FAU - Wu, Shu-Ju AU - Wu SJ AD - Taipei Medical University, Taiwan. FAU - Tam, Ka-Wai AU - Tam KW FAU - Tsai, Ya-Hui AU - Tsai YH FAU - Chang, Chun-Chao AU - Chang CC FAU - Chao, Jane C-J AU - Chao JC LA - eng PT - Journal Article PL - Singapore TA - Am J Chin Med JT - The American journal of Chinese medicine JID - 7901431 RN - 0 (Anti-Inflammatory Agents) RN - 0 (Cytokines) RN - 0 (NF-kappa B) RN - 0 (Plant Extracts) RN - 0 (Saponins) RN - 0 (Transforming Growth Factor beta1) RN - 6SMK8R7TGJ (Oleanolic Acid) RN - 9007-34-5 (Collagen) RN - CL2T97X0V0 (Carbon Tetrachloride) RN - IT942ZTH98 (Curcumin) RN - RMB44WO89X (Hydroxyproline) RN - UR635J3F00 (saikosaponin D) SB - IM MH - Animals MH - Anti-Inflammatory Agents/isolation & purification/pharmacology/*therapeutic use MH - Bupleurum/chemistry MH - Carbon Tetrachloride MH - Chemical and Drug Induced Liver Injury/*drug therapy/metabolism MH - Collagen/metabolism MH - Curcuma/chemistry MH - Curcumin/isolation & purification/pharmacology/*therapeutic use MH - Cytokines/metabolism MH - Dietary Supplements MH - Drug Therapy, Combination MH - Fibrosis/chemically induced/metabolism/*prevention & control MH - Hydroxyproline/metabolism MH - Inflammation/chemically induced/metabolism/*prevention & control MH - Liver/metabolism MH - Male MH - NF-kappa B/antagonists & inhibitors MH - Oleanolic Acid/*analogs & derivatives/isolation & purification/pharmacology/therapeutic use MH - Phytotherapy MH - Plant Extracts/chemistry/pharmacology/*therapeutic use MH - Plant Roots MH - Random Allocation MH - Rats MH - Rats, Sprague-Dawley MH - Rhizome MH - Saponins/isolation & purification/pharmacology/*therapeutic use MH - Transforming Growth Factor beta1/metabolism EDAT- 2010/02/04 06:00 MHDA- 2010/04/23 06:00 CRDT- 2010/02/04 06:00 PHST- 2010/02/04 06:00 [entrez] PHST- 2010/02/04 06:00 [pubmed] PHST- 2010/04/23 06:00 [medline] AID - S0192415X10007695 [pii] AID - 10.1142/S0192415X10007695 [doi] PST - ppublish SO - Am J Chin Med. 2010;38(1):99-111. doi: 10.1142/S0192415X10007695.